Quality & Safety
NABH evidence that assembles itself · incidents, HAI surveillance, medication safety, mortality review, clinical audit, risk & SOPs · Sister Vasavi · 18 Jul 2026
Readiness by chapter
| Status | Chapter | Standards | Objective elements | Evidence source in HOS | What is missing |
|---|---|---|---|---|---|
| Complete | 1 · Patient Registration & Identification | 4 / 4 | 9 / 9 | Reception registration log, ABHA linkage, duplicate-merge trail | — |
| 1 gap | 2 · Clinical Documentation & EMR | 5 / 6 | 12 / 13 | AI Scribe notes with approver, case sheets, discharge summaries | WHO Surgical Safety Checklist, digitally signed |
| 1 gap | 3 · Order Management & Results | 4 / 5 | 10 / 11 | Lab order → sample → result chain, TAT clocks, radiology orders | Critical-result alerting with recorded acknowledgement |
| 4 gaps | 4 · Medication Management | 4 / 5 | 8 / 12 | Rx with approver, dispense log, high-alert double-signatures, error reports | Closed-loop administration (barcode at the bedside) — 4 elements hang off this one capability |
| Complete | 5 · Data Privacy & Security | 5 / 5 | 11 / 11 | Role permissions, break-glass log, hash-chained audit trail, DPDP consent artefacts | — |
| 4 gaps | 6 · Interoperability & Data Exchange | 3 / 4 | 6 / 10 | ABDM M1 ✓ M2 ✓, FHIR R4 exports, ABHA-linked outside records | ABDM M3 (health-information exchange) certification — in progress |
| Complete | 7 · Infrastructure & Technology Management | 4 / 4 | 9 / 9 | Uptime record, backup verification, downtime drill log | — |
| 3 gaps | 8 · Analytics, Quality & Governance | 4 / 5 | 6 / 9 | Quality indicators, incident & CAPA register, mortality reviews, clinical audits | 12 continuous months of indicator submission — you are at 8 |
| Total | 8 chapters | 33 / 38 | 71 / 84 | — | 13 elements outstanding |
Evidence collected for you
What HOS cannot collect
Six records filed this week are usable as accreditation evidence, and none of them were created for that purpose. The mapping below is a suggestion — nothing is filed against a standard until you approve it.
| Record | Maps to | Why |
|---|---|---|
| QI-2026-034 Patient fall, GM-07, 14 Jul |
8.2 · OE b | Incident captured, investigated and a CAPA assigned with an owner and a due date |
| MED-2026-041 Dispensing near-miss, 16 Jul |
4.4 · OE a | Medication error reported and analysed by stage of the medication process |
| HH-R-2026-96 Hand-hygiene round, ICU, 17 Jul |
8.3 · OE c | Compliance measured by WHO moment against an observed denominator |
| MR-2026-08 Mortality review signed off, 15 Jul |
8.4 · OE a | Death reviewed by a committee with the finding recorded |
| CA-2026-01 Surgical prophylaxis re-audit, 12 Jul |
8.1 · OE b | Audit cycle closed with a measured change against the same criterion |
| QSP-08 v1.0 Patient identification SOP, 01 Jul |
1.2 · OE a | Controlled, versioned procedure with dated staff acknowledgements |
Report an incident
Severity mix this month
Of the 4 falls recorded this quarter, 3 share three recorded fields: they happened on the general ward between 02:00 and 04:00, the patient had a night sedative administered that shift, and the side-rail was recorded as down. QI-2026-021 (28 Jun), QI-2026-029 (06 Jul) and QI-2026-034 (14 Jul).
The fourth fall — QI-2026-018, OPD waiting area, 11 Jun — shares none of them.
Suggested single CAPA in place of three separate ones: side-rail check recorded at the 02:00 round for every patient with a sedative charted that shift. Owner and due date are yours to set.
Recent reports
| Severity | Report | Ward | Reported | Stage |
|---|---|---|---|---|
| Minor | QI-2026-034 Patient fall · side-rail recorded down |
GM-07 | 14 Jul · 03:22 Mary Grace · 38 s |
Investigating |
| Near-miss | QI-2026-033 Wrong strength drawn up, caught at second check |
ICU-2 | 13 Jul · 21:40 Anonymous · 41 s |
Closed |
| Moderate | QI-2026-032 IV cannula infiltration, extra 2 days of dressings |
GF-01 | 11 Jul · 07:15 Mary Grace · 52 s |
CAPA open |
| Near-miss | QI-2026-031 Blood sample labelled at the counter, not at the bedside |
Lab | 09 Jul · 11:02 Prasad · 44 s |
CAPA open |
| Minor | QI-2026-029 Patient fall · found beside bed, no injury |
GM-03 | 06 Jul · 02:55 Anonymous · 36 s |
CAPA overdue |
| Near-miss | QI-2026-028 Oxygen cylinder trolley without a wheel chock |
GM corridor | 04 Jul · 16:30 Ravi Teja · 29 s |
Closed |
CAPA tracker
| Status | Action | Owner | Due | Type |
|---|---|---|---|---|
| Overdue 6 d | Side-rail check recorded at the 02:00 round from QI-2026-029 |
Mary Grace | 12 Jul | Preventive |
| Overdue 3 d | Generator load-test log moved into HOS from QI-2026-026 · power dip during a dressing |
Dr. G. Prakash | 15 Jul | Preventive |
| Due in 3 d | Bedside labelling: printer at the phlebotomy trolley from QI-2026-031 |
Prasad | 21 Jul | Corrective |
| Due in 8 d | Cannula site check added to the 4-hourly nursing round from QI-2026-032 |
Mary Grace | 26 Jul | Corrective |
| Closed 11 Jul | Wheel chocks fitted to all four O₂ trolleys from QI-2026-028 · effectiveness check passed 16 Jul |
Ravi Teja | 10 Jul | Corrective |
| Closed 08 Jul | Second-check signature enforced for insulin draws from QI-2026-033 · 24 of 24 draws double-signed since |
Sister Vasavi | 08 Jul | Preventive |
Investigation — QI-2026-034 · patient fall, GM-07, 14 Jul
Device-associated infection rates — Jun 2026 (closed month)
| Indicator | Confirmed cases | Device-days | Rate | Device utilisation | Definition applied |
|---|---|---|---|---|---|
| CAUTI Catheter-associated urinary tract infection |
2 | 412 | 4.85 2 ÷ 412 × 1,000 |
0.29 412 ÷ 1,436 |
CDC/NHSN UTI criteria · symptomatic UTI with catheter ≥ 2 days |
| CLABSI Central line-associated bloodstream infection |
0 | 96 | 0.00 0 ÷ 96 × 1,000 |
0.56 96 ÷ 172 ICU-days |
CDC/NHSN LCBI · recognised pathogen from blood, line ≥ 2 days |
| VAP Ventilator-associated pneumonia |
1 | 84 | 11.90 1 ÷ 84 × 1,000 |
0.49 84 ÷ 172 ICU-days |
CDC/NHSN PNEU criteria · a single case moves this rate by 11.9, so read the count first |
| SSI Surgical site infection · different denominator |
3 | 86 procedures, not days |
3.5% 3 ÷ 86 |
— | CDC/NHSN SSI · clean and clean-contaminated procedures, 30-day follow-up |
Device-days, live — July to date
| Indicator | Patient · device | Inserted | Device-days so far | Source |
|---|---|---|---|---|
| CAUTI catheter-days |
B. Srinu · GM-05, Foley catheter | 15 Jul, 14:20 | 4 15–18 Jul inclusive, ongoing |
Nursing → Catheter care |
| VAP ventilator-days |
S. Ramulamma · ICU-2, ventilator | 17 Jul, 06:40 | 2 17–18 Jul inclusive, ongoing |
IPD → ICU & Emergency |
Cases meeting a recorded surveillance definition — July to date
| Your call | Patient | What is recorded | Definition | |
|---|---|---|---|---|
| Awaiting you | Yadamma B., 64F GF-04 · admitted 08 Jul |
Urine culture 15 Jul: E. coli >10⁵ CFU/mL · indwelling catheter charted from 09 Jul (day 7) · fever 38.4 °C charted 14 Jul | Meets CDC/NHSN symptomatic UTI with catheter ≥ 2 days | |
| Awaiting you | K. Shankaraiah, 58M ICU-2 · ventilated from 10 Jul |
Tracheal aspirate 16 Jul: Klebsiella pneumoniae, ESBL+ · ventilator-days charted 10–17 Jul · CXR report 15 Jul notes a new infiltrate | Meets CDC/NHSN PNEU criteria on the recorded elements | |
| Awaiting you | B. Srinu, 67M GM-05 · TKR 15 Jul |
Wound swab 17 Jul: Staph. aureus, MSSA · purulent discharge recorded in the 17 Jul dressing note · day 3 post-procedure | Meets CDC/NHSN superficial incisional SSI on the recorded elements |
Your culture log holds 3 Klebsiella pneumoniae isolates from ICU beds between 06 and 17 Jul, all reported ESBL-positive with the same recorded antibiogram (resistant to ceftriaxone and cefotaxime, sensitive to meropenem). ICU-2 (16 Jul), ICU-5 (11 Jul), ICU-7 (06 Jul). The three months before this held 2 such isolates in total.
Recorded alongside them: hand-hygiene compliance in ICU measured 68.2% in the same window (30 of 44 observed opportunities), and ceftriaxone accounts for 51% of your antimicrobial DDDs.
This is a count of what is in your log, not an outbreak determination. Whether these isolates are related — and whether that relationship is transmission — is a question for the infection control committee, and if needed for typing at a reference lab. HOS has assembled the numbers so that meeting starts with facts instead of a search.
Hand-hygiene rounds — Jun 2026
Antimicrobial usage — Jun 2026
| Antimicrobial | AWaRe | DDD | per 100 pt-days |
|---|---|---|---|
| Ceftriaxone | Watch | 412 | 28.7 |
| Amoxicillin-clavulanate | Access | 188 | 13.1 |
| Piperacillin-tazobactam | Watch | 96 | 6.7 |
| Azithromycin | Watch | 72 | 5.0 |
| Meropenem | Watch | 42 | 2.9 |
| Total | Access 23% · Watch 77% · Reserve 0% | 810 | 56.4 |
Notifiable disease reporting — IDSP / IHIP
| Status | Event | Basis in the record | Form |
|---|---|---|---|
| Reported | Dengue Mohd. Irfan, 34M · 12 Jul |
NS1 antigen positive, LAB-4519, reported by Prasad 12 Jul 09:40 | IHIP Form P · submitted 12 Jul 11:05 by Sister Vasavi |
| Reported | Measles — suspected Child, 3F · 04 Jul |
Clinical case definition recorded by Dr. Meena Iyer; serology sent | IHIP Form S · submitted 04 Jul 17:20 by Sister Vasavi |
| Draft ready | Enteric fever Patient consented, 17 Jul |
Blood culture: Salmonella Typhi, LAB-4536, reported 17 Jul 18:10 | IHIP Form P pre-filled · needs your submission |
Where in the medication process
The nine that reached a patient
What Pharmacy's dispense safety net does and doesn't catch
High-alert medications
| Compliance | Drug | Doses | Double-signed | Storage rule |
|---|---|---|---|---|
| 95.8% | Insulin (regular & premix) | 48 | 46 | Separate fridge bin, never in the general drawer |
| 91.7% | Heparin (UFH & LMWH) | 24 | 22 | Strength-segregated shelf, tall-man labelled |
| 100% | Potassium chloride concentrate | 8 | 8 | Never on the ward — pharmacy-diluted only |
| 91.2% | Opioids (morphine, fentanyl) | 34 | 31 | Double-locked, shift-wise register count |
| 100% | Methotrexate (weekly oral) | 2 | 2 | Weekly-dose warning sticker, dispensed per week |
| 94.0% | All high-alert doses | 116 | 109 | 109 ÷ 116 = 94.0% |
Look-alike / sound-alike pairs in your own formulary
| Control | Pair | Caught | Why they collide here |
|---|---|---|---|
| Tall-man + split shelf | Ceftriaxone / Cefotaxime | 3 | Both stocked as 1 g vials, adjacent bins, near-identical labels |
| Tall-man + split shelf | MetFORMIN / MetroNIDAZOLE | 2 | Both 500 mg tablets, both high-volume, both start "Met" |
| Tall-man only | amLODIPine / amIODARone | 1 | Amiodarone is stocked for ICU; shelves are not yet separated |
| Tall-man only | clonazePAM / cloBAZam | 1 | Both in the controlled cupboard, spoken orders sound alike |
| No control yet | Losartan / Lisinopril | 0 | Newly stocked together on 01 Jul · flagged, no control applied |
41 reports, 32 intercepted, 9 reached a patient, none with harm above moderate. Prescribing is the largest stage at 14, and 8 of those 14 were a missing frequency or an ambiguous verbal order — both fixable in the prescribing screen rather than by training. Three of the nine that reached a patient were paediatric weight-based dose errors, all in the 4–7 PM pediatric OPD.
Two items need a committee decision, not a CAPA: Losartan / Lisinopril are now stocked adjacently with no control applied, and the 7 unsigned high-alert doses were all on the night shift, which is a staffing question rather than a compliance one.
Batch recall — Inj. Ceftriaxone 1 g, CFX-2607-B
| Where the batch went | Vials | Status |
|---|---|---|
| Administered to patients 04 – 18 Jul · 23 patients · most recent dose 09:15 today · traced from the barcode administration record, not from paper |
71 | Exposure identified |
| Issued to sub-stores, not yet administered OT store 12 · Emergency 6 |
18 | Recall from sub-stores |
| On the main pharmacy shelf Batch is still dispensable until it is quarantined |
31 | Quarantine |
| Received on GRN, 04 Jul 2026 MedPlus Distributors · full batch accounted for |
120 | 71 + 18 + 31 = 120 |
Case list
| Review status | Case | Admitted → died | Recorded diagnosis | Committee |
|---|---|---|---|---|
| Packet needed | MR-2026-09 G. Ramulamma, 78F · GF-03 |
12 Jul → 16 Jul 4 days |
Community-acquired pneumonia with type 1 respiratory failure as recorded by Dr. K. Ramesh | Not yet scheduled |
| In review | MR-2026-08 B. Sridevi, 71F · GM-04 |
04 Jul → 09 Jul 5 days |
Sepsis of urinary origin as recorded by Dr. K. Ramesh | Circulated 11 Jul · meets 21 Jul |
| In review | MR-2026-07 M. Anjaneyulu, 66M · ICU-5 |
26 Jun → 30 Jun 4 days |
Acute myocardial infarction, cardiogenic shock as recorded by Dr. K. Ramesh | Circulated 03 Jul · meets 21 Jul |
| Signed off 15 Jul | MR-2026-06 S. Narsamma, 82F · GF-05 |
08 Jun → 21 Jun 13 days |
Aspiration pneumonia in advanced dementia | Finding recorded · 1 learning point |
| Signed off 02 Jul | MR-2026-05 K. Yellaiah, 59M · ICU-2 |
31 May → 07 Jun 7 days |
Intracerebral haemorrhage | Finding recorded · 2 learning points |
| Signed off 18 Jun | MR-2026-04 P. Lakshmamma, 74F · GF-02 |
19 May → 24 May 5 days |
Decompensated cirrhosis with hepatic encephalopathy | Finding recorded · 1 learning point |
| Signed off 30 May | MR-2026-03 A. Mallesh, 68M · ICU-7 |
02 May → 11 May 9 days |
Diabetic foot sepsis with acute kidney injury | Finding recorded · 3 learning points |
| Signed off 14 May | MR-2026-02 V. Kanakamma, 85F · GF-04 |
21 Apr → 26 Apr 5 days |
Fractured neck of femur, post-operative pneumonia | Finding recorded · 2 learning points |
| Signed off 06 May | MR-2026-01 D. Satyanarayana, 71M · GM-06 |
05 Apr → 12 Apr 7 days |
Chronic obstructive pulmonary disease, acute exacerbation | Finding recorded · 1 learning point |
Everything in her record from admission on 12 Jul to death on 16 Jul, in order, as one document: 4 nursing shift handovers, 26 vitals sets, 31 medication administrations, 5 laboratory reports, 2 chest radiograph reports, 3 consultant notes, 1 rapid-response record from 15 Jul 04:10, the oxygen and NIV charting, and the family communication log. 72 pages. Assembling this by hand takes the quality nurse most of a morning.
Three review steps are outstanding and the committee cannot complete the review without them:
Those three gaps are statements about the documentation, not about the care. What happened, and whether anything should have gone differently, is for the committee to determine and record in its own words.
Structured review — MR-2026-08 · B. Sridevi, 71F
Learning carried forward
The cycle — CA-2026-01 · surgical antibiotic prophylaxis
Open audit cycles
| Stage | Audit | Criterion | Cycle complete | Lead |
|---|---|---|---|---|
| Re-audit done | CA-2026-01 Surgical antibiotic prophylaxis · from MR-2026-02 |
≥ 95% within 60 min of incision | 5 / 6 88% vs 95% |
Dr. P. Anil Kumar |
| Change made | CA-2026-02 Case-sheet completeness within 24 h of admission |
100% of admissions have a complete case sheet by 24 h | 4 / 6 first round 71% |
Dr. K. Ramesh |
| Measuring | CA-2026-03 Blood transfusion consent & reaction monitoring |
Consent on file and vitals at 0/15/60 min for every unit | 3 / 6 18 of 24 units sampled |
Sister Vasavi |
| Sampling | CA-2026-04 Culture before empirical antibiotics · from MR-2026-03 |
≥ 80% of suspected sepsis admissions have a culture sent first | 2 / 6 baseline 44% in Jun |
Dr. K. Ramesh |
Four cycles ran; one reached re-audit. Surgical prophylaxis moved 54% → 88% after the OT checklist prompt and the pre-drawn dose, and the remaining 6 misses were all the first procedure of the day — a supply-timing pattern, not a compliance one. Case-sheet completeness measured 71% at baseline and its change (a 24-hour prompt to the admitting doctor) landed on 01 Jul, so a re-audit is possible from August. Transfusion monitoring is 18 of 24 units sampled. Culture-before-antibiotics has a baseline of 44%, which is the same figure the antimicrobial usage card reports independently.
One honest note for the report: three of the four cycles have no re-audit date booked, and a cycle without one tends to become a survey.
5 × 5 matrix
Register
| Score | Risk | Mitigation & owner | Review due | Escalation |
|---|---|---|---|---|
| 20 L4 × I5 |
R-01 · Single oxygen manifold, no redundant supply A manifold failure affects every oxygen-dependent bed at once |
Second manifold quoted ₹4.2L; 12 backup cylinders held on site meanwhile Dr. G. Prakash |
31 Jul 2026 | Board · 08 Jul |
| 16 L4 × I4 |
R-02 · Ceftriaxone-first prescribing culture 77% of antimicrobial DDDs are WHO Watch group; 3 ESBL+ isolates in ICU this month |
Antimicrobial stewardship policy drafted; culture-first audit CA-2026-04 running Dr. K. Ramesh |
15 Aug 2026 | Quality committee |
| 15 L3 × I5 |
R-06 · Fire NOC expires 14 Sep 2026 Renewal needs a mock drill record and a hydrant pressure test |
Drill booked 02 Aug; hydrant test quoted Dr. G. Prakash |
28 Jul 2026 | Board · watch |
| 12 L3 × I4 |
R-03 · No barcode verification at the bedside 3 of 9 errors that reached a patient this month are the type a scan catches |
Second-check signature policy enforced (94.0% this month); closed-loop eMAR on the HOS roadmap Ravi Teja |
20 Aug 2026 | Quality committee |
| 12 L4 × I3 |
R-04 · Night-shift nursing ratio 1:12 on the general ward All 7 unsigned high-alert doses and 2 of 3 recent falls were on nights |
One additional night post costed at ₹28,000/month; awaiting owner's decision Mary Grace |
05 Aug 2026 | Owner decision |
| 9 L3 × I3 |
R-05 · Biomedical waste segregation lapses at source Sharps found in the yellow bag on 3 of 12 spot checks |
Colour-coded bin retraining; SOP QSP-04 is itself overdue for review Sister Vasavi |
Overdue · 10 Jul | Section level |
| 8 L2 × I4 |
R-08 · Single orthopedic surgeon covers all OT lists Elective lists stop entirely during leave; revenue dipped 12% last time |
Visiting-surgeon arrangement under discussion with two candidates Dr. G. Prakash |
30 Aug 2026 | Owner |
| 6 L3 × I2 |
R-07 · Generator load-test not documented monthly A power dip during a dressing became incident QI-2026-026 |
Load-test log being moved into HOS; CAPA is itself 3 days overdue Dr. G. Prakash |
Overdue · 30 Jun | Section level |
Quality & safety SOP set
| Acknowledged | SOP | Version | Effective | Review due | Owner |
|---|---|---|---|---|---|
| 38 / 42 | QSP-01 · Hand hygiene & PPE 4 staff have not acknowledged v4.2 |
v4.2 | 01 Apr 2026 | 01 Apr 2027 | Sister Vasavi |
| 42 / 42 | QSP-02 · Incident reporting (no-blame) Full acknowledgement — the only SOP at 100% besides code blue |
v3.0 | 12 May 2026 | 12 May 2027 | Sister Vasavi |
| 29 / 42 | QSP-03 · High-alert medication double-check 13 outstanding · 7 doses missed a second signature this month |
v2.1 | 20 Jun 2026 | 20 Jun 2027 | Ravi Teja |
| 40 / 42 | QSP-04 · Biomedical waste segregation Review overdue 3 d and risk R-05 is open against it |
v5.0 | 15 Jan 2026 | 15 Jul 2026 | Sister Vasavi |
| 31 / 42 | QSP-05 · Blood transfusion & reaction monitoring Clinical audit CA-2026-03 is measuring against this SOP now |
v2.0 | 03 Mar 2026 | 03 Sep 2026 | Sister Vasavi |
| 22 / 42 | QSP-06 · WHO surgical safety checklist 20 outstanding · the digital signature on this is a NABH chapter-2 gap |
v1.3 | 08 Feb 2026 | 08 Aug 2026 | Dr. P. Anil Kumar |
| 42 / 42 | QSP-07 · Code blue / CPR Full acknowledgement · quarterly mock drill 12 Jul, 4 min 20 s response |
v3.1 | 25 Apr 2026 | 25 Apr 2027 | Dr. K. Ramesh |
| 18 / 42 | QSP-08 · Patient identification & the five rights New on 01 Jul · 24 outstanding, so do not yet treat this as in force |
v1.0 | 01 Jul 2026 | 01 Jul 2027 | Sister Vasavi |
| 262 / 336 78.0% |
8 SOPs × 42 staff | — | — | 1 overdue · 2 due in 90 d | — |